Table 1 Study and study participants characteristics (n = 7)
Study, Year | Study Design | Setting and Geographic Location | Collection Year | Data Domain | Sample Size (% women) | Age (years) | BMI (kg/m2) | Duration of Symptoms (months) |
|---|---|---|---|---|---|---|---|---|
Dunn et al., 2004 [4] | Population-based cohort | Community in the USA | 2001–2002 | Prevalence | 784 (56.7%) | 74.5 ± 6.0 | 38% had BMI ≥ 30 | NA |
Yi et al., 2011 [9] | Retrospective review of medical records | Foot clinic at a general hospital in South Korea | 2008 | Prevalence & diagnostic criteria | 250 (54.4%) | 43.8 ± 12.0 | NR | 13.3 ± 17.4 |
Kanatli et al., 2001 [15] | Observational case–control | NR in Turkey | NR | Etiology | 106 contributing 188 feet (56.6%) | 34.8 ± 12.9 | 26.1 ± 5.6 | NR |
Lopez-Lopez et al., 2019 [16] | Observational case–control | Podiatry department at a medical center in Spain | 2008–2015 | Etiology and diagnostic criteria | 375 (47.2%) | 44.7 ± 14.1 | 26.5 ± 5.8 | NR |
Balius et al., 2021 [17] | Observational case series | Outpatient clinic of sports medicine and rheumatology in Spain | NR | Etiology | 9 (NR) | 31 ± 8.5 | NR | 2.46 ± 3.72 |
Lin et al., 2017 [18] | Single case study | NR in Taiwan | NR | Intervention | 1 male (0%) | 33 | NR | 36 + |
Chae et al., 2018 [19] | Quasi-experimental intervention (no control group) | Foot clinic at a general hospital in South Korea | 2015–2016 | Intervention | 19 contributing 32 feet (73.7%) | 51.5 ± 14.1 | 22.6 ± 2.6 | NR |